Skip to main content
PBF logo

PBF — Investor Relations & Filings

Ticker · 1760 ISIN · TW0001760007 LEI · 54930078VUU2LBPR2729 TW Manufacturing
Open in API
Filings indexed 1,562 across all filing types
Latest filing 2020-12-29 Capital/Financing Update
Country TW Taiwan
Listing TW 1760

About PBF

http://www.pbf.com.tw

Panion & BF Biotech Inc. is a biotechnology company focused on pharmaceutical research, development, and manufacturing. Founded in 1976, the firm operates across several core sectors, including new drug innovation, medical aesthetics, and nutritional supplements. It is recognized for its "Total Aging Management" strategy, which addresses the health needs of an aging population through a diverse product portfolio. Key offerings include treatments for chronic kidney disease, specifically phosphate binders, as well as dermatological drugs, hair care solutions, and rapid diagnostic technologies. The company integrates clinical-grade pharmaceutical standards into its consumer health and aesthetic products, serving markets in chronic disease care and preventative wellness.

Recent filings

Filing Released Lang Actions
本公司董事會通過資金貸與全資子公司正峰化學製藥股份有限公司
Capital/Financing Update Classification · 95% confidence The document is a short announcement (1048 characters) from a listed company disclosing a board-approved loan of funds to its wholly owned subsidiary. It details the loan amount, interest rate, repayment terms, and financial status of the subsidiary. There is no comprehensive financial data, no full report, and no mention of an attached or published report. The content is about a financing activity (loan to subsidiary), which fits the Capital/Financing Update category. It is not a full financial report, audit, or earnings release. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2020-12-29 Chinese
公告本公司產品"飛確"新型冠狀病毒抗原快速檢驗試劑取得 新加坡HSA臨時授權許可
Regulatory Filings Classification · 95% confidence The document is a short announcement (810 characters) from a company about obtaining provisional authorization from the Singapore Health Sciences Authority for a COVID-19 antigen rapid test product. It is a regulatory announcement about a product approval, not a financial report, earnings release, or management discussion. It does not contain financial data or detailed report content. It is not a report publication announcement since it does not mention any report being published or attached. The content fits best under Regulatory Filings (RNS) as a general regulatory announcement about company product approval.
2020-12-24 Chinese
109年11月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a company (寶齡富錦) regarding the status of fund loans and endorsement guarantees for the current and previous months, with amounts all reported as zero. The content is very short (603 characters) and consists mainly of tabular data about financial guarantees and loans, without any detailed financial statements, management discussion, or regulatory certifications. It does not contain any narrative or detailed financial performance data typical of annual or interim reports. It also does not announce any voting results, management changes, or legal proceedings. Given the brevity and nature of the data, this document is best classified as a Regulatory Filing (RNS), which serves as a general category for miscellaneous regulatory disclosures that do not fit other specific categories.
2020-12-09 Chinese
109年11月營業收入
Interim / Quarterly Report Classification · 90% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 寶齡富錦, presented in a tabular format with explanations about accounting standards and reporting practices. It contains financial data for a specific month (November of 民國109年, which corresponds to 2020) and cumulative year-to-date figures, including percentage changes compared to the previous year. The document is relatively short (774 characters) and focuses on financial performance metrics for a partial period rather than a full fiscal year. It does not appear to be a full annual report or an earnings release announcement but rather a periodic financial report with substantive financial data. Given these characteristics, the document best fits the definition of an Interim / Quarterly Report (IR), which covers comprehensive financial data for a period shorter than a full fiscal year. Q4 2020
2020-12-09 Chinese
109年11月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document contains detailed tables listing shareholdings of company insiders, including directors, managers, and their related parties. It shows changes in shareholdings, stock types, and other related data. The content is focused on insider share transactions and holdings rather than financial results, management changes, or other corporate events. There is no indication of it being a full financial report, earnings release, or regulatory announcement about voting or dividends. The document is a report of personal share transactions by company directors and executives, which matches the definition of Director's Dealing (DIRS). The document length is sufficient and contains substantive data, not just an announcement or certification.
2020-12-07 Chinese
109年11月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed information about shareholdings and pledged shares of company insiders, including directors, supervisors, and executives. It lists their current holdings, pledged shares, and related percentages. The content is focused on insider shareholdings and pledges rather than financial results, management changes, or meeting materials. There is no indication of a report publication, earnings release, or regulatory certification. The document is a disclosure of insider shareholdings and pledges, which aligns with the category of Director's Dealing (DIRS), as it reports personal share transactions or holdings by company directors and executives.
2020-12-07 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.